फार्मास्युटिका एनालिटिका एक्टा

अमूर्त

Linezolid

Giovanni Tosi

Linezolid is an anti-infection utilized for the treatment of
diseases brought about by Gram-positive microbes that are
impervious to different anti-infection agents. Linezolid is
dynamic against most Gram-positive microbes that cause
infection, including streptococci, vancomycin-safe enterococci
(VRE), and methicillin-safe Staphylococcus aureus (MRSA). The
principle utilizes are diseases of the skin and pneumonia in spite
of the fact that it very well might be utilized for an assortment of
different contaminations including drug-safe tuberculosis. It is
utilized either by infusion into a vein or by mouth. At the point
when given for brief periods, linezolid is a generally protected
anti-infection.